Cedric Francois

This inventor holds 43 USPTO granted patents and 50 published patent applications, plus 5 CIPO patents and 13 EPO patents, primarily in Complement Inhibition. Top assignees: Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Apellis Holdings, LLC. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cedric Francois. Retrieved from https://idiyas.com/inventor/cedric-francois

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 (Patent Applications = 50)

% Patents Active = 90.7

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 13 (Patent Applications = 26)

Average Co-Inventor Count = 2.3

ph-index = 12

Forward Citations = 379(Granted Patents)

Location History:

Louisville, KY (US) (2011 - 2018)
Crestwood, KY (US) (2017 - 2022)
Prospect, KY (US) (2015 - 2024)

Company Filing History:

25 out of 27

Apellis Pharmaceuticals, Inc.

patents

5 out of 5

Potentia Pharmaceuticals, Inc.

patents

4 out of 4

Apellis Holdings, LLC

patents

4. 3 out of 4

Zyus Life Sciences US Ltd.

Sixth Street Lending Partners

patent

7. 3 out of 834,453

Other

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Dosing Regimens

Complement Inhibitors

Compstatin Analogs

Chronic Disorders

Patient State Representation

Breathing Assistance

Neuropathic Pain

Position-Sensing Lenses

Phagocytosis Enhancement

Allergic Desensitization

Age-Related Macular Degeneration

Complement Assays

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741036 - VIRAL VECTOR THERAPY (2026-09-22),

2. 12528836 - DOSING REGIMENS (2026-01-20),

3. 12458695 - Dosing regimens and related compositions and methods (2025-11-04),

4. 12290566 - Dosing regimens and related compositions and methods (2025-05-06),

5. 11903994 - Dosing regimens (2024-02-20),

6. 11844841 - Dosing regimens and related compositions and methods (2023-12-19),

7. 11712460 - Methods of treating chronic disorders with complement inhibitors (2023-08-01),

8. 11661441 - Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof (2023-05-30),

9. 11529283 - Apparatus and methods for assisting breathing (2022-12-20),

10. 11407789 - Cell-penetrating compstatin analogs and uses thereof (2022-08-09),

11. 11338013 - Combination therapy for C3 inhibition (2022-05-24),

12. 11292815 - Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods (2022-04-05),

13. 11291407 - Detection of high risk drusen (2022-04-05),

14. 11152114 - Patient state representation architectures and uses thereof (2021-10-19),

15. 11101026 - Schedule-based electronic medical record modules, applications, and uses thereof (2021-08-24),

Title: Inventor Cedric Francois: Revolutionizing Healthcare

Introduction: Cedric Francois, a visionary inventor hailing from Prospect, KY (US), is making significant strides in the field of healthcare with his groundbreaking innovations.

Latest Patents: Cedric Francois holds several patents in the medical field, including advancements in personalized medicine, drug delivery systems, and diagnostic tools.

Career Highlights: Dr. Francois has a distinguished career as a physician, entrepreneur, and inventor. He founded Apellis Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapies for autoimmune diseases.

Collaborations: Cedric Francois has collaborated with leading researchers, medical professionals, and scientists to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge medical technologies.

Conclusion: Cedric Francois continues to push the boundaries of innovation in healthcare, with a relentless dedication to improving patient outcomes and revolutionizing the medical industry.

Profile summary based on public USPTO records.